Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors [NA]
Clinical trial update for an exercise intervention in ovarian cancer survivors; study status terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer [Phase 2]
Phase 2 trial evaluating intraoperative intraperitoneal chemoperfusion for treating minimal residual disease in stage III ovarian cancer and…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval [Phase 3]
Phase 3 trial assessing chemotherapy to treat ovarian cancer recurrence by prolonging platinum-free interval.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer [Phase 1]
Phase 1 trial update of PIPAC nab-paclitaxel for peritoneal carcinomatosis in stomach, pancreas, breast, and ovarian cancers with completed …
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. [Phase 1]
Phase 1 trial evaluating safety, pharmacokinetics, and efficacy of Ipatasertib with Rucaparib in advanced breast, ovarian, and prostate canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A Phase I/II study evaluating atezolizumab in combination with olaparib in patients with advanced solid tumors, including ovarian, breast, s…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating the addition of tremelimumab to olaparib for recurrent ovarian, fallopian tube, or primary peritoneal cancer; the s…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: BrUOG 390: Neoadjuvant Treatment With Talazoparib [Phase 1]
Phase 1 neoadjuvant study of talazoparib in BRCA1/BRCA2 mutation-associated cancers ( ovarian/fallopian tube high-grade serous carcinoma) ha…
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating oral minoxidil for recurrent platinum-resistant epithelial ovarian cancer (Ovarian Cancer) is underway; cu…
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors [Phase 1]
Phase 1 results for a study combining the TORC1/2 inhibitor MLN0128 (sapanisertib) with bevacizumab in adults with recurrent glioblastoma or…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action [Phase 4]
A Phase 4 clinical trial investigates how using different anesthetics affects prognosis in primary tumors and explores the mechanism of acti…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: IMX-110 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for IMX-110 in adults with advanced solid tumors across Phase 1 and Phase 2 is listed, with multiple solid tumor ind…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for SC0191 combined with chemotherapy in advanced serous ovarian cancer, currently in Phase 1/Phase 2, sponsor Biocity…
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) [Phase 1]
Phase 1 trial evaluating autologous T cells with or without cyclophosphamide and fludarabine for recurrent or persistent advanced ovarian ep…
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients [Phase 2]
Phase 2 trial assessing hetrombopag for primary prevention of niraparib-induced thrombocytopenia in advanced ovarian cancer patients; effica…
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial update evaluating gemcitabine hydrochloride with or without the WEE1 inhibitor adavosertib in patients with recurrent…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating vargatef added to first-line chemotherapy with interval debulking surgery in ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer [Phase 2]
Phase 2 trial update evaluating paclitaxel plus pazopanib for platinum-resistant/refractory ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Myocet (doxorubicin liposome) plus carboplatin in relapsed, platinum-sensitive ovarian cancer complete…
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating plasmid Elenagen in combination with gemcitabine for platinum-resistant ovarian cancer; status and results are not …
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: BEACON - ABC in Recurrent Platinum Resistant HGSOC [Phase 2]
Phase 2 trial update for BEACON program in recurrent platinum-resistant high-grade serous ovarian cancer (HGSOC).
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: EP0057 in Combination With Olaparib in Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial update for EP0057 in combination with olaparib in advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer [Phase 1, Phase 2]
A combined aribulin with carboplatin and bevacizumab trial in ovarian cancer is in Phase 1/2 with status unknown.
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy [Phase 2]
A Phase 2 trial evaluating Fluzoparib in combination with QL1101 as maintenance therapy after response to front-line platinum in advanced ov…